| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1748-5827.2006.00094.X |
| P8608 | Fatcat ID | release_ukogrb4r4vfenin4qsijmg7zym |
| P698 | PubMed publication ID | 16573762 |
| P2093 | author name string | Thompson H | |
| Argyle DJ | |||
| Nixon C | |||
| Mellor D | |||
| Knottenbelt C | |||
| P2860 | cites work | Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs in canine blood | Q28192382 |
| Rectal neoplasia in the dog: a clinicopathological review of 31 cases | Q39806892 | ||
| In vitro effects of nonsteroidal anti-inflammatory drugs on cyclooxygenase activity in dogs | Q40868431 | ||
| A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. | Q41145531 | ||
| Adenomatous polyps and carcinoma in situ of the canine colon and rectum: 34 cases (1982-1994). | Q41438538 | ||
| Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer | Q43812726 | ||
| Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma. | Q50881116 | ||
| COX-2 is expressed in human pulmonary, colonic, and mammary tumors. | Q53402915 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 196-200 | |
| P577 | publication date | 2006-04-01 | |
| P1433 | published in | Journal of Small Animal Practice | Q15762435 |
| P1476 | title | Cohort study of COX-1 and COX-2 expression in canine rectal and bladder tumours. | |
| P478 | volume | 47 |
| Q94570414 | Aberrant expression of the COX2/PGE2 axis is induced by activation of the RAF/MEK/ERK pathway in BRAFV595E canine urothelial carcinoma |
| Q86969849 | COX-2 expression in canine anal sac adenocarcinomas and in non-neoplastic canine anal sacs |
| Q37597583 | Cancer, cyclo-oxygenase and nonsteroidal anti-inflammatory drugs - can we combine all three? |
| Q64078145 | Correlation of BRAF Variant V595E, Breed, Histological Grade and Cyclooxygenase-2 Expression in Canine Transitional Cell Carcinomas |
| Q37793667 | Cyclooxygenase-2 Expression in Animal Cancers |
| Q53093929 | Differences in expression of uroplakin III, cytokeratin 7, and cyclooxygenase-2 in canine proliferative urothelial lesions of the urinary bladder. |
| Q38712705 | Molecular investigation of the direct anti-tumour effects of nonsteroidal anti-inflammatory drugs in a panel of canine cancer cell lines. |
| Q37202773 | Role of the prostaglandin pathway and the use of NSAIDs in genitourinary malignancies |
Search more.